# Efficacy and Safety of Intramuscular Injection of Xiyanping Injection in the Treatment of Acute Bronchitis in Children

> **NCT04926506** · NA · UNKNOWN · sponsor: **Jiangxi Qingfeng Pharmaceutical Co. Ltd.** · enrollment: 80 (estimated)

## Conditions studied

- Acute Bronchitis in Children

## Interventions

- **DRUG:** Xiyanping injection

## Key facts

- **NCT ID:** NCT04926506
- **Lead sponsor:** Jiangxi Qingfeng Pharmaceutical Co. Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-10-08
- **Primary completion:** 2022-09-21
- **Final completion:** 2022-12-30
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2021-10-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04926506

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04926506, "Efficacy and Safety of Intramuscular Injection of Xiyanping Injection in the Treatment of Acute Bronchitis in Children". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT04926506. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*